Home Tags Anti-PD-L1 inhibitor

Tag: anti-PD-L1 inhibitor

Strategic Immuno-Oncology Collaboration Between Celgene and MedImmune Focuses on Non-Hodgkin’s Lymphoma,...

Celgene, headquartered in Summit, New Jersey, and MedImmune (Gaithersburg, Maryland), a wholly owned subsidiary of AstraZeneca, have entered into a strategic collaboration to develop and...

X